Francisco Javier
López Jiménez
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitari de Bellvitge (4)
2023
-
Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study
British Journal of Haematology, Vol. 203, Núm. 2, pp. 182-193
2022
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205
2019
-
Posaconazole salvage therapy: The Posifi study
Mycoses, Vol. 62, Núm. 6, pp. 526-533
2014
-
Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: A multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study
British Journal of Haematology, Vol. 164, Núm. 5, pp. 668-674